Tidmarsh George F's Form 4/A amendment
AmendedRevelation Biosciences, Inc. (REVB) · filed Feb 9, 2022
- Accession no.
- 0001209191-22-008025
- Filed
- Feb 9, 2022
- Trade date
- Feb 4-7, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Feb 8, 2022
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $133.0K. It was filed 5 days after the trade.
This amendment replaces 0001209191-22-007837 (filed Feb 8, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tidmarsh George FCIK 0001287235 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2022 | Common Stock | PPurchaseAcquired | +7,900 | $2.31 | +$18,249 | 1,481,235 | Indirect | |
| Feb 7, 2022 | Common Stock | PPurchaseAcquired | +42,100 | $2.61 | +$109,881 | 1,523,335 | Indirect | |
| Feb 4, 2022 | Common Stock | PPurchaseAcquired | +2,000 | $2.45 | +$4,900 | 416,156 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.